Medtronic (MDT) Research & Development (2016 - 2026)
Medtronic's Research & Development history spans 13 years, with the latest figure at $722.0 million for Q1 2026.
- On a quarterly basis, Research & Development rose 6.96% to $722.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $2.9 billion, a 5.99% increase, with the full-year FY2025 number at $2.7 billion, changed 0.11% from a year prior.
- Research & Development hit $722.0 million in Q1 2026 for Medtronic, down from $754.0 million in the prior quarter.
- Over the last five years, Research & Development for MDT hit a ceiling of $754.0 million in Q4 2025 and a floor of $641.0 million in Q2 2023.
- Historically, Research & Development has averaged $687.5 million across 5 years, with a median of $684.0 million in 2025.
- The widest YoY moves for Research & Development: up 11.15% in 2022, down 7.73% in 2022.
- Tracing MDT's Research & Development over 5 years: stood at $676.0 million in 2022, then grew by 3.25% to $698.0 million in 2023, then fell by 0.14% to $697.0 million in 2024, then rose by 8.18% to $754.0 million in 2025, then fell by 4.24% to $722.0 million in 2026.
- Business Quant data shows Research & Development for MDT at $722.0 million in Q1 2026, $754.0 million in Q4 2025, and $726.0 million in Q3 2025.